No Data
No Data
Analysts Offer Insights on Healthcare Companies: Aldeyra Therapeutics (ALDX), LAVA Therapeutics (LVTX) and Crinetics Pharmaceuticals (CRNX)
Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study
Aldeyra Therapeutics (ALDX) said Wednesday the first patient has been enrolled in a phase 3 dry eye chamber trial of reproxalap in dry eye disease. Reproxalap is an investigational reactive aldehyde s
Express News | Aldeyra Therapeutics Enrolls First Patient in Phase 3 Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease, Clinical Results and Potential New Drug Application Submission Expected In 2H Of 2024
Express News | Aldeyra Therapeutics Inc - Clinical Results and Potential New Drug Application Submission Expected in Second Half of 2024
Express News | Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease
No Data